Company: LNAI
Filing Date: 2025-11-14
Form Type: 10-Q
Source: 0001731122-25-001544
Chunk: 2

Company: Lunai Bioworks Inc.
Filing Date: 2025-11-14
Form: 10-Q
Item: Part I, Item 1
Chunk 2
---
)

(53,338,554
)

Other Income (Expense)

Change in fair value of contingent consideration

370,000

9,250,000

Change in fair value of equity securities

156,849

—

Gain on bankruptcy of subsidiary

12,019,227

—

Loss on extinguishment of debt

(6,329,592
)

—

Interest expense

(122,400
)

(250,080
)

Interest income and other income (expense)

33,297

126,598

Total Other Income (Expense)

6,127,381

9,126,518

NET INCOME (LOSS)
 
$
2,819,021

$
(44,212,036
)

BASIC AND DILUTED INCOME (LOSS PER SHARE)
 
$
0.13

$
(2.76
)

WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK OUTSTANDING – BASIC
AND DILUTED

22,520,245

15,999,337

See accompanying notes to the unaudited condensed consolidated
financial statements.

3

LUNAI BIOWORKS INC. AND SUBSIDIARIES

 CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE
LOSS

(UNAUDITED)

For the Three Months Ended

September 30,

2025
 
2024

Net Income (Loss)
 
$
2,819,021

$
(44,212,036
)

Other Comprehensive Income (Loss)

Foreign Currency Translation, net of taxes

(10,943,003
)

6,468,061

Comprehensive Loss
 
$
(8,123,982
)
 
$
(37,743,975
)

See accompanying notes to the unaudited condensed consolidated
financial statements.

4

LUNAI BIOWORKS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’
EQUITY (DEFICIT)

(UNAUDITED)

# of Common Shares
 
Common Shares Amount
 
Additional Paid-In Capital
 
Accumulated Deficit
 
Accumulated Other Comprehensive Income (Loss)
 
Total

June 30, 2024

15,845,264

1,585

464,601,486

(332,455,081
)

(170,846
)

131,977,144

Issuance of common stock under private placement offering

142,346

14

2